ALFA FinderNSE filing, NSE: CURIS. Summary written from the filing by ALFA Finder's alert engine.
Curis Lifesciences Ltd: key numbers
- Share price
- ₹170.70
- Market cap
- ₹138.0 Cr
- Revenue (annual)
- ₹60.63 Cr
- Net profit (annual)
- ₹6.92 Cr
- P/E (TTM)
- 19.9×Sector 43.8×
- Promoter holding
- 68.03%
- FII holding
- 1.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Curis Lifesciences Ltd
All →Curis Lifesciences Other Announcement
Curis Lifesciences filed its Reg 32 statement of IPO fund utilisation for the half-year to September 30, 2026. The filing reports no deviation or variation, with ₹2,295.11 lakhs utilised against ₹2,752 lakhs proposed.
Curis Lifesciences H1 FY27 Results: Net Profit ₹4.1 Cr, Down 2.4% YoY
Curis Lifesciences Ltd reported revenue from operations of ₹34.1 Cr (+22.2% YoY) and net profit of ₹4.1 Cr (-2.4% YoY) for H1 FY27.
- Key figure
- Net profit ₹4.1 Cr · -2.4% YoY
Curis Lifesciences Other Announcement
Curis Lifesciences Limited informed that it is not required to submit a Corporate Governance Report, as its securities are listed on the SME platform.
Curis Lifesciences Annual General Meeting
Curis Lifesciences Limited conducted its 10th Annual General Meeting on September 29, 2026, to transact various agenda items, including financial statement adoption and director appointments.
Curis Lifesciences Annual General Meeting
Curis Lifesciences filed its 10th AGM notice and FY 2025-26 Annual Report. The meeting is scheduled for September 29, 2026.
Curis Lifesciences Board Meeting Outcome
Curis Lifesciences Limited approved the Director's Report, related party transactions, and scheduled its 10th Annual General Meeting for September 29, 2026. Board outcomes were finalized.
Other board meeting date announcements
All →RRP Defense Board Meeting Date
RRP Defense Ltd scheduled a board meeting for 14 Nov 2026 to consider Q2 and half-year financial results. No decisions have been taken yet; agenda items are proposed only.
Sukhjit Starch & Chemicals Board Meeting Date
Sukhjit Starch & Chemicals will consider a buyback proposal at its board meeting on 20 November 2026. The trading window stays closed until the meeting concludes.
Dhruva Capital Services Board Meeting Date
Dhruva Capital Services postponed its Q2/H1 FY27 results Board Meeting to November 13, 2026. The trading window stays closed until November 15, 2026.
Mitshi India Board Meeting Date
Mitshi India rescheduled its board meeting from 13 Nov to 14 Nov 2026 due to non-availability of directors. The meeting's agenda includes Q2/H1 2026 financial results approval.
Magnus Steel and Infra Board Meeting Date
Magnus Steel and Infra has scheduled its board for 14 Nov 2026 to approve standalone results for the quarter and half year ended 30 Sep 2026. The trading window is closed from 1 Oct 2026.
Ansal Properties & Infrastructure Board Meeting Date
Ansal Properties & Infrastructure intimated that its Board will meet on 18 Nov 2026 to approve Q1 FY27 standalone results. The meeting is scheduled and has not yet been held.